SEC Comment Letter for Pluri Inc. (PLUR) (CIK 0001158780) (PLUR) — Apr 6, 2017
Pluri Inc. (PLUR) (CIK 0001158780)
Date: April 6, 2017 · CIK: 0001158780 · Accession: 0000000000-17-011854
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-31392
Letter
Mail Stop 4546 April 6, 2017 Erez Egozi Chief Financial Officer Pluristem Therapeutics Inc. Matam Advanced Technology Park Building No. 5 Haifa, Israel, 31905
Re: Pluristem Therapeutics Inc. Form 10-K for the Fiscal Year Ended June 30, 2016 Filed September 7, 2016 File No. 001-31392
Dear Mr. Egozi :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Erin K. Jaskot, for
Show Raw Text
Mail Stop 4546 April 6, 2017 Erez Egozi Chief Financial Officer Pluristem Therapeutics Inc. Matam Advanced Technology Park Building No. 5 Haifa, Israel, 31905 Re: Pluristem Therapeutics Inc. Form 10-K for the Fiscal Year Ended June 30, 2016 Filed September 7, 2016 File No. 001-31392 Dear Mr. Egozi : We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Erin K. Jaskot, for Suzanne Hayes Assistant Director Office of Healthcare and Insurance Cc: Oded Har -Even, Esq. Zysman, Aharoni, Gayer and Sullivan & Worcester LLP